Dose of vitamin D in children with chronic kidney disease

Optimal dose of cholecalciferol supplementation in Indian children with chronic kidney disease-A randomised control trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/11/010385

Enrollment

Registered

2017-11-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Kidney disease Health Condition 2: N183- Chronic kidney disease, stage 3 (moderate)

Interventions

Intervention1: Vitamin D cholecalciferol: Doses- 3000 units /day vs 25000 units/week vs 1,00,000 units/month orally for 3 months followed by 1000 units daily for 9 months Control Intervention1: No com

Eligibility

Inclusion criteria

Inclusion criteria: Chronic kidney disease stages 2 to 4 (eGFR 15-90 ml/min/1.73m2) with vitamin D level <30ng/ml

Exclusion criteria

Exclusion criteria: those children who have received vitamin D supplements in the last 3 months

Design outcomes

Primary

Measure	Time frame
Serum levels of vitamin D 30ng/ml at completion of therapy at 3 monthsTimepoint: Serum levels of vitamin D 30ng/ml at completion of therapy at 3 months	—

Secondary

Measure	Time frame
To maintain the normal vitamin D level (30ng/ml) with maintenance therapyTimepoint: at 6, 9 and 12 months	—

Countries

India

Contacts

Public ContactDr Arpana Iyengar

St. Johns Medical College, Bangalore

arpanaiyengar@gmail.com09880372660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026